Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Shares Issued (2022 - 2024)

Day One Biopharmaceuticals (DAWN) has disclosed Shares Issued for 4 consecutive years, with -$748000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Shares Issued changed N/A to -$748000.0 in Q4 2025 year-over-year; TTM through Sep 2025 was $748000.0, a 96.31% decrease, with the full-year FY2024 number at $20.9 million, changed N/A from a year prior.
  • Shares Issued was -$748000.0 for Q4 2025 at Day One Biopharmaceuticals, down from $748000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $161.6 million in Q2 2022 to a low of -$160.7 million in Q3 2023.
  • A 4-year average of $1.7 million and a median of $186000.0 in 2024 define the central range for Shares Issued.
  • Biggest YoY gain for Shares Issued was 112.8% in 2024; the steepest drop was 99.8% in 2024.
  • Day One Biopharmaceuticals' Shares Issued stood at -$2.1 million in 2022, then surged by 68.19% to -$653000.0 in 2023, then skyrocketed by 3249.92% to $20.6 million in 2024, then plummeted by 103.64% to -$748000.0 in 2025.
  • Per Business Quant, the three most recent readings for DAWN's Shares Issued are -$748000.0 (Q4 2025), $748000.0 (Q3 2025), and $20.6 million (Q3 2024).